Anthony Mirhaydari

InvestorPlace Market Strategist

Anthony Mirhaydari is founder of the Edge and Edge Pro investment advisory newsletters.

He is an independent investment columnist with work appearing at Investorplace, The Fiscal Times, CBS News MoneyWatch, MSN Money, Yahoo Finance, and Dow Jones MarketWatch. He started covering the markets and the economy in the media in 2008 in the midst of the greatest financial crisis in generations.

Previously, he was a senior research analyst with Markman Capital Insight, an advisory and money management firm, and a business consulting analyst with Moss Adams focusing on the financial-services industry.

Recent Articles

5 Tech Giants Set to Report Earnings (And Rattle the Market)

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 29, 2018

Big tech stocks have been the primary motivators of the market's melt-up. But with options traders bracing for volatility -- either up or down -- nearly $200 billion in overall market value is at risk. Here are the five biggies to watch for:

5 Biotech and Pharmaceutical Stocks Going Bonkers

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 26, 2018

These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.

The VIX Keeps Forging Its Way Higher

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 26, 2018

In a breaking of the long-held tradition of rising stocks and falling volatility, the VIX is moving higher despite the relentless gains in equity prices.

Dollar Rout Dings Stocks

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 25, 2018

Stocks finished with quiet gains. But the closing numbers mask the churning, volatile session that marked a 300-point swing in the Dow Jones from its high into an excursion into negative territory.

7 Overbought Stocks to Watch as the Market Turns

By Anthony Mirhaydari, InvestorPlace Market Strategist Jan 24, 2018

With a downturn seemingly underway, here are the seven of the most overbought stocks vulnerable to a nasty lurch lower.